Relapse Prevention in Berlin, NJ

Relapse does not start with a drink. It starts weeks earlier, and relapse prevention is the practice of noticing that.

Anyone who has been through it knows the drink or the bag was the last step, not the first. Before it came the skipped meeting, the argument nobody resolved, the sleep that fell apart, the old number that somehow was not deleted. Relapse prevention therapy is the discipline of catching the early steps, and of having a plan for the late ones. This page explains how it works, what the research adds, why the risk of overdose is highest right after a period of not using, and how relapse prevention runs at South Jersey Recovery Program in Berlin, NJ.

What is relapse prevention therapy?

Relapse prevention is a cognitive behavioral approach developed by the psychologist G. Alan Marlatt and colleagues in the 1980s. Its starting assumption is that relapse is a process with identifiable steps, not a sudden collapse of willpower.

Three ideas do most of the work.

High-risk situations. Marlatt’s research found that most relapses cluster around a small set of situations: negative emotional states, conflict with other people, and social pressure. Knowing your own list is the first task.

Seemingly irrelevant decisions. Driving home past the old bar “because the traffic is better.” Keeping the bottle “for guests.” Each choice looks harmless alone. Together they walk a person to the edge of a high-risk situation and let the situation do the rest.

The abstinence violation effect. After a lapse, the thought “I have blown it, so it does not matter now” turns one drink into a week. Relapse prevention treats that thought as the most dangerous moment of the whole sequence.

A lapse is one event.

A relapse is what you decide it means.

How does relapse actually unfold?

Many clinicians describe relapse in three stages (Melemis, Yale Journal of Biology and Medicine, 2015). It is a working model, not a diagnosis, and it is useful because the first two stages are where the intervention is cheap.

Stage	What it looks like	What to do
Emotional	Isolating, skipping sessions, poor sleep, bottling anger, no self-care. Not thinking about using yet	Name it out loud to someone. Fix sleep, food, and structure first
Mental	Bargaining, glamorizing the past, thinking about people and places tied to using, planning “just once”	Tell your therapist or sponsor the same day. Use the written plan
Physical	The drink, the pill, the call	Reach out immediately. Do not wait for the abstinence violation effect to make it worse

Most people enter treatment believing relapse begins at stage three. Most relapses were preventable at stage one.

What does the research say about relapse prevention?

A 1999 meta-analysis of 26 studies covering more than 9,000 people (Irvin and colleagues, Journal of Consulting and Clinical Psychology) found relapse prevention was effective overall, with the strongest results for alcohol and polysubstance use. The effect was largest in studies using uncontrolled before-and-after measurement, which is a reason to read the number as encouraging rather than settled.

Mindfulness-based relapse prevention, which adds meditation and urge-surfing practice to the standard model, has one of the better single trials in the field. Bowen and colleagues randomized 286 people finishing intensive treatment to mindfulness-based relapse prevention, standard relapse prevention, or usual twelve-step aftercare (JAMA Psychiatry, 2014). At twelve months, the mindfulness group reported fewer drug-use days and less heavy drinking than either comparison group.

For stimulant use disorder, where no FDA-approved medication exists, the 2024 ASAM and AAAP clinical practice guideline identifies contingency management, a structured program of rewards for verified abstinence, as the treatment with the strongest evidence.

Verify what a program actually delivers. “Relapse prevention” on a brochure can mean a worksheet or a course of treatment. Ask what happens in the sessions.

What medications help prevent relapse?

Therapy is half of it. For two conditions, medication is the other half, and the standard of care is both together.

• Alcohol use disorder: naltrexone, acamprosate, and disulfiram are FDA-approved. Naltrexone blunts the reward of drinking; acamprosate eases the protracted discomfort after stopping; disulfiram makes drinking physically unpleasant
• Opioid use disorder: buprenorphine, methadone, and naltrexone are FDA-approved. Buprenorphine and methadone control craving and withdrawal; extended-release naltrexone blocks opioids outright. Methadone for opioid use disorder is dispensed only through licensed opioid treatment programs

No FDA-approved medication exists for cannabis, cocaine, or methamphetamine use disorder. For those, the plan is behavioral. Contingency management, a program of rewards for verified abstinence, has the strongest evidence and is delivered by specialized programs; we do not offer it. Here, CBT and structured support carry the load.

Our medication assisted treatment page covers how these medications fit into outpatient care here.

The overdose risk after a period of not using

This is the part of relapse prevention that can be fatal to skip.

Tolerance to opioids falls within days of stopping. A person who leaves treatment, a hospital, or jail and returns to the dose that was normal before is now taking an overdose. Most overdose deaths in New Jersey involve fentanyl, increasingly alongside the sedatives xylazine and medetomidine, according to NJ CARES, the state’s overdose data program, which makes the margin thinner still. Tolerance also falls for alcohol and benzodiazepines, and the combination of either with an opioid is a common way a return to use becomes fatal.

Every relapse prevention plan for someone with an opioid history includes three things: naloxone in the house and on the person, someone who knows how to use it (call 911 first, give a dose, repeat every 2 to 3 minutes in alternating nostrils until help arrives, and stay), and the instruction to call 911 for any suspected overdose. Our family therapy page walks through the steps for the people you live with. New Jersey’s Overdose Prevention Act protects people who call for help from certain drug possession charges; verify the details, but the rule is simple. Call.

What goes into a written relapse prevention plan?

The plan is a document, not a feeling. Yours will be written with your therapist, shared with the people you choose, and revised as treatment goes on.

Element	Example
Your high-risk situations	Friday after payday; visits to a specific relative; being alone after an argument
Early warning signs	Skipping meals, sleeping past noon, going quiet in group
Coping responses	Urge surfing for twenty minutes; a call before a decision; leaving the location
People to call, in order	Therapist, sponsor or peer, a specific family member, the SAMHSA helpline at 1-800-662-4357
Rules for the first hour after a lapse	Who you tell, what you do not do, where you go
Medication and medical	Naloxone location; prescriber contact; refill dates
Structure	Meeting schedule, work hours, sleep and exercise commitments
Crisis	988 for a mental health crisis, 911 for an emergency

The plan is the thing you read when you cannot think.

Write it while you can.

Where relapse prevention fits at South Jersey Recovery Program

We are an outpatient provider in Berlin, NJ. We do not offer medically supervised detox or residential treatment; if you need either, we will say so and help arrange it.

Relapse prevention here starts in the first week, not the last. In partial care and intensive outpatient, you go home every evening, which means you are testing the plan against real life while you still have a treatment team the next morning. Skills come from CBT for the thinking and DBT for the emotion. Family sessions put the household’s role on a hard day in writing. Group therapy is where you hear how other people’s relapses actually started, which is the fastest education there is.

When the structured programs end, outpatient care keeps the plan current. Stepping down a level of care is a slope, not a cliff, and the plan is what you carry down it.

Questions people ask about relapse prevention

Does a relapse mean I have to start over?

No. The skills and the time were not erased. What matters is how fast you reach out afterward, and the plan is built to make that fast. Come back. We would rather see you the same day than a month later.

How long is someone at risk of relapse?

Risk is highest in the first year and falls with time, but addiction is a chronic condition. The National Institute on Drug Abuse compares its relapse rates to those of other chronic illnesses like hypertension and asthma, which is an argument for ongoing care, not for despair.

Is relapse prevention the same as aftercare?

Aftercare is the level of care. Relapse prevention is the content. A good aftercare plan is mostly a relapse prevention plan with appointments attached.

Can I get naloxone without a prescription in New Jersey?

Yes. It is available at New Jersey pharmacies without a prescription, and many community programs distribute it free. Ask us and we will point you to the nearest source.

The bottom line

Relapse is a process, and processes have early steps.

Willpower is what you use at the last step. A plan is what you use at the first.

Write the plan while you are well.

Call (856) 788-6914 or contact us online to talk about treatment, or about coming back. The assessment is free, and we can verify your insurance on the same call.

Sources

• Melemis SM. Relapse prevention and the five rules of recovery. Yale Journal of Biology and Medicine, 2015.
• Marlatt GA, Gordon JR, editors. Relapse Prevention: Maintenance Strategies in the Treatment of Addictive Behaviors. Guilford Press, 1985.
• Irvin JE, Bowers CA, Dunn ME, Wang MC. Efficacy of relapse prevention: a meta-analytic review. Journal of Consulting and Clinical Psychology, 1999.
• Bowen S, Witkiewitz K, Clifasefi SL, et al. Relative efficacy of mindfulness-based relapse prevention, standard relapse prevention, and treatment as usual for substance use disorders: a randomized clinical trial. JAMA Psychiatry, 2014.
• American Society of Addiction Medicine and American Academy of Addiction Psychiatry. Clinical Practice Guideline on the Management of Stimulant Use Disorder, 2024.
• National Institute on Drug Abuse. Principles of Drug Addiction Treatment: A Research-Based Guide, third edition, 2018.
• New Jersey Overdose Prevention Act, P.L. 2013, c. 46.
• NJ CARES, Office of the New Jersey Attorney General. Overdose data and reporting. njoag.gov/programs/nj-cares.
• New Jersey Department of Health. New Jersey Marks Progress in Reducing Overdose Deaths While Honoring Lives Lost. August 29, 2025.
• SAMHSA. Opioid Overdose Prevention Toolkit: Five Essential Steps for First Responders, 2018.

---

This page is for general education and is not a substitute for individualized medical advice. If you or someone else is in immediate danger, call 911. For a mental health crisis, call or text 988. For free, confidential treatment referrals, call the SAMHSA National Helpline at 1-800-662-4357.